Total Payments
$86,888
2024 Payments
$8,329
Companies
94
Transactions
1,669
Medicare Patients
22,350
Medicare Billing
$2.9M
Payment Breakdown by Category
Other$49,814 (57.3%)
Food & Beverage$33,961 (39.1%)
Travel$1,519 (1.7%)
Consulting$1,200 (1.4%)
Education$393.52 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,814 | 37 | 57.3% |
| Food and Beverage | $33,961 | 1,609 | 39.1% |
| Travel and Lodging | $1,519 | 9 | 1.7% |
| Consulting Fee | $1,200 | 1 | 1.4% |
| Education | $393.52 | 13 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $31,204 | 185 | $0 (2024) |
| Allergan, Inc. | $19,086 | 76 | $0 (2021) |
| Amgen Inc. | $5,370 | 99 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,205 | 161 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,969 | 162 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $2,623 | 23 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $1,721 | 18 | $0 (2021) |
| Novo Nordisk Inc | $1,540 | 91 | $0 (2024) |
| PFIZER INC. | $1,284 | 79 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,144 | 52 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,329 | 173 | ABBVIE INC. ($4,429) |
| 2023 | $17,894 | 219 | AbbVie Inc. ($12,764) |
| 2022 | $15,998 | 237 | ABBVIE INC. ($11,041) |
| 2021 | $8,729 | 219 | AbbVie Inc. ($2,811) |
| 2020 | $21,139 | 204 | Allergan, Inc. ($18,099) |
| 2019 | $3,461 | 180 | AstraZeneca Pharmaceuticals LP ($751.01) |
| 2018 | $4,913 | 214 | AstraZeneca Pharmaceuticals LP ($750.53) |
| 2017 | $6,425 | 223 | Avanir Pharmaceuticals, Inc. ($2,437) |
All Payment Transactions
1,669 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Bone Health | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $33.23 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $92.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: VACCINE | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 5,220 | 17,531 | $1.2M | $677,200 |
| 2022 | 41 | 5,607 | 17,034 | $1.3M | $795,884 |
| 2021 | 45 | 5,771 | 17,964 | $1.4M | $791,166 |
| 2020 | 42 | 5,752 | 16,395 | $1.2M | $646,868 |
Total Patients
22,350
Total Services
68,924
Medicare Billing
$2.9M
Procedure Codes
175
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 543 | 2,061 | $309,150 | $200,020 | 64.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 281 | 283 | $99,050 | $52,641 | 53.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 315 | 326 | $97,800 | $45,707 | 46.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 2,300 | $55,200 | $41,493 | 75.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 290 | 293 | $80,575 | $39,499 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 299 | 504 | $57,960 | $34,573 | 59.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 107 | 497 | $49,700 | $25,675 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $35,200 | $23,846 | 67.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 15 | 1,801 | $36,020 | $23,219 | 64.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 55 | 480 | $48,000 | $20,502 | 42.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 55 | 480 | $36,000 | $19,553 | 54.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 57 | $17,670 | $15,701 | 88.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 119 | 119 | $17,850 | $15,289 | 85.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 92 | 388 | $29,050 | $15,244 | 52.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 51 | 332 | $21,580 | $10,959 | 50.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 154 | 164 | $18,696 | $10,333 | 55.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 36 | 2,880 | $28,800 | $10,093 | 35.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 98 | 101 | $17,170 | $8,584 | 50.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 99 | 99 | $7,920 | $7,505 | 94.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 220 | 576 | $17,280 | $6,486 | 37.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 42 | 43 | $12,900 | $6,293 | 48.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 186 | 188 | $6,956 | $6,110 | 87.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $8,200 | $4,408 | 53.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 330 | 348 | $8,700 | $3,676 | 42.3% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $6,400 | $3,254 | 50.8% |
About Dr. Aditya Chopra, MD
Dr. Aditya Chopra, MD is a Internal Medicine healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508850991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aditya Chopra, MD has received a total of $86,888 in payments from pharmaceutical and medical device companies, with $8,329 received in 2024. These payments were reported across 1,669 transactions from 94 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,814).
As a Medicare-enrolled provider, Chopra has provided services to 22,350 Medicare beneficiaries, totaling 68,924 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Annapolis, MD
- Active Since 08/31/2005
- Last Updated 05/02/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508850991
Products in Payments
- UBRELVY (Drug) $29,994
- QULIPTA (Drug) $18,302
- Repatha (Biological) $3,106
- NUEDEXTA (Drug) $2,595
- NURTEC ODT (Drug) $2,286
- TRELEGY ELLIPTA (Drug) $1,826
- FARXIGA (Drug) $1,393
- VRAYLAR (Drug) $1,171
- SYMBICORT (Drug) $1,002
- XARELTO (Drug) $908.94
- Aimovig (Biological) $854.85
- JARDIANCE (Drug) $808.45
- GEMTESA (Drug) $702.36
- Ozempic (Drug) $701.78
- ANORO (Drug) $651.62
- REXULTI (Drug) $612.21
- BREZTRI (Drug) $600.75
- Kerendia (Drug) $568.88
- PENNSAID (Drug) $550.09
- EVENITY (Biological) $549.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Annapolis
Dr. Brian Harvey, Md, MD
Internal Medicine — Payments: $355,038
Internal Medicine $355,038
James Welker, D.o, D.O
Internal Medicine — Payments: $29,365
Internal Medicine $29,365
Dr. Darshana Purohit, Md, MD
Internal Medicine — Payments: $28,062
Internal Medicine $28,062
Mr. Jack Lichtenstein, Md, MD
Internal Medicine — Payments: $21,464
Internal Medicine $21,464
Dr. Prasad Savana, Md, MD
Internal Medicine — Payments: $17,282
Internal Medicine $17,282
Alan Weiss, Md, MD
Internal Medicine — Payments: $10,194
Internal Medicine $10,194